Loading the company…
Loading the company…
Families: Tumor & fibroid embolization.
All companies · Product and company coverage
In the last ten years FDA made 2 decisions for Shape Memory Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2019 (1). The latest was on 2019-05-23.
| Family | Decisions on record |
|---|---|
| Tumor & fibroid embolization | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2019-05-23 | 510(k) | K182390 | IMPEDE-FX Embolization Plug |
| 2018-06-22 | 510(k) | K181051 | IMPEDE Embolization Plug, 5mm, IMPEDE Embolization Plug, 7mm, IMPEDE Embolization Plug, 10mm |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Shape Memory Medical.
In 2025, Shape Memory Medical reported engagement with 342 surgeons and other clinicians in the states MedaRep covers, worth $81K in consulting, speaking, meals and travel for its device products, the most in New York ($22K to 38). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New York ($22K, 38 engaged), Wisconsin ($19K, 5 engaged), Texas ($8,056, 41 engaged), Virginia ($5,368, 44 engaged), Florida ($3,047, 32 engaged).